Randolf Brehler Selected Research

Allergens

9/2023	Impact of climate change on allergic diseases in Germany.
1/2023	Allergic asthma: An indication for allergen immunotherapy.
1/2023	Diagnosis and treatment of Hymenoptera venom allergy: S2k Guideline of the German Society of Allergology and Clinical Immunology (DGAKI) in collaboration with the Arbeitsgemeinschaft für Berufs- und Umweltdermatologie e.V. (ABD), the Medical Association of German Allergologists (AeDA), the German Society of Dermatology (DDG), the German Society of Oto-Rhino-Laryngology, Head and Neck Surgery (DGHNOKC), the German Society of Pediatrics and Adolescent Medicine (DGKJ), the Society for Pediatric Allergy and Environmental Medicine (GPA), German Respiratory Society (DGP), and the Austrian Society for Allergy and Immunology (ÖGAI).
1/2021	White paper on peanut allergy - part 1: Epidemiology, burden of disease, health economic aspects.
1/2017	A Case of Severe Anaphylaxis to Polyhexanide: Cross-Reactivity between Biguanide Antiseptics.
8/2015	Allergy--current insights into prevention and diagnostic workup of immediate-type allergy and treatment of allergic rhinoconjunctivitis.
1/2011	Suitability of different glycoproteins and test systems for detecting cross-reactive carbohydrate determinant-specific IgE in hymenoptera venom-allergic patients.
1/2003	Positive effects of a fresh air filtration system on hay fever symptoms.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Randolf Brehler Research Topics

Disease

16	Hypersensitivity (Allergy) 09/2023 - 01/2002
7	COVID-19 11/2022 - 01/2020
6	Chronic Urticaria 08/2023 - 07/2011
5	Asthma (Bronchial Asthma) 09/2023 - 09/2008
5	Anaphylaxis (Anaphylactic Shock) 01/2023 - 08/2013
4	Urticaria (Hives) 10/2019 - 07/2011
3	Eczema 01/2023 - 01/2022
3	Allergic Rhinitis 01/2023 - 09/2008
2	Bites and Stings (Sting) 01/2023 - 08/2013
2	Contact Dermatitis (Eczema, Contact) 01/2022 - 01/2020
2	Syphilis 04/2021 - 01/2021
2	Venom Hypersensitivity 01/2020 - 08/2013
2	Pruritus (Itching) 10/2011 - 07/2011
1	Atopic Dermatitis (Atopic Eczema) 09/2023
1	Respiratory Tract Diseases (Respiratory Tract Disease) 01/2023
1	Mastocytosis 01/2023
1	Immediate Hypersensitivity 11/2022
1	Allergic Contact Dermatitis 01/2022
1	Peanut Hypersensitivity (Peanut Allergy) 01/2021
1	Severe Acute Respiratory Syndrome 01/2021
1	Inflammation (Inflammations) 01/2021
1	Drug Hypersensitivity (Drug Allergy) 01/2020
1	Solar Urticaria 01/2018
1	Chronic Inducible Urticaria 01/2018
1	Cold Urticaria 01/2018
1	Angioedema 01/2018
1	Familial dermographism 01/2018
1	Rhinitis 09/2016
1	Insect Bites and Stings (Insect Bite) 08/2013
1	Food Hypersensitivity (Food Allergy) 03/2011
1	Rhinosinusitis 01/2008
1	Spinal Dysraphism (Spina Bifida) 01/2002

Drug/Important Bio-Agent (IBA)

8	AllergensIBA 09/2023 - 01/2003
7	Omalizumab (Xolair)FDA Link 01/2023 - 01/2008
6	anti-IgE antibodiesIBA 01/2023 - 01/2008
6	Immunoglobulin E (IgE)IBA 01/2017 - 01/2002
5	Arthropod VenomsIBA 01/2023 - 01/2011
5	VaccinesIBA 11/2022 - 01/2021
4	AntibodiesIBA 01/2017 - 03/2011
3	Penicillins (Penicillin)FDA Link 04/2021 - 01/2020
3	CarbohydratesIBA 08/2013 - 01/2011
2	VenomsIBA 01/2023 - 01/2011
2	Epinephrine (Adrenaline)FDA LinkGeneric 01/2023 - 01/2021
2	Bee Venoms (Bee Venom)IBA 01/2023 - 01/2011
2	Messenger RNA (mRNA)IBA 11/2022 - 01/2021
2	COVID-19 VaccinesIBA 11/2022 - 01/2021
2	LactaseIBA 09/2016 - 10/2011
1	Air Pollutants (Pollutants, Air)IBA 09/2023
1	Non-Sedating Histamine H1 Antagonists (Histamine H1 Antagonists, Non Sedating)IBA 08/2023
1	rupatadineIBA 08/2023
1	Tryptases (Tryptase)IBA 01/2023
1	mRNA VaccinesIBA 11/2022
1	Irritants (Vesicants)IBA 01/2022
1	BNT162 VaccineIBA 01/2021
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2020
1	Cephalosporins (Cephalosporin Antibiotics)IBA 01/2020
1	Monoclonal AntibodiesIBA 01/2020
1	beta Lactam AntibioticsIBA 01/2020
1	beta-LactamsIBA 01/2020
1	Leukotriene Antagonists (Leukotriene Receptor Antagonists)IBA 10/2019
1	ligelizumabIBA 10/2019
1	Cholinergic Agents (Cholinergics)IBA 01/2018
1	Local Anti-Infective Agents (Antiseptics)IBA 01/2017
1	ChlorhexidineIBA 01/2017
1	BiguanidesIBA 01/2017
1	polihexanideIBA 01/2017
1	TabletsIBA 09/2016
1	Dapsone FDA Link 11/2011
1	Lactose FDA LinkGeneric 10/2011
1	AutoantigensIBA 07/2011
1	Histamine Antagonists (Antihistamines)IBA 07/2011
1	AutoantibodiesIBA 07/2011
1	Polysaccharides (Glycans)IBA 03/2011
1	Peptides (Polypeptides)IBA 03/2011
1	Xylose (D-Xylose)FDA Link 03/2011
1	FucoseIBA 03/2011
1	Glycoproteins (Glycoprotein)IBA 03/2011
1	Rubber (Elastica)IBA 01/2002

Therapy/Procedure

13	Therapeutics 01/2023 - 07/2011
4	Immunotherapy 01/2020 - 09/2008
1	Off-Label Use 01/2023
1	Emergency Treatment 01/2021
1	Drug Therapy (Chemotherapy) 01/2020
1	Injections 05/2010